PIK3CA and lung cancer: The PI3K signalling pathway is deregulated in a broad spectrum of human cancers, and PIK3CA is frequently mutated or amplified in many human cancers, including breast, colon, gastric, cervical, prostate, and lung cancer (reviewed in [211,212]).